NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) - ANVISA Registration 10071770882

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770882 and manufactured by ABBOTT RAPID DIAGNOSTICS JENA GMBH. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Mar 27, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including ROCHE MOLECULAR SYSTEMS, INC, ZHEJIANG ORIENT GENE BIOTECH CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
3 Competitors
10071770882
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770882
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10071770882

25351055154201657

50248780000161

Company Information

Germany
PT: ALEMANHA

Dates and Status

Mar 27, 2017

27/03/2027

09/18/2025 19:00:01

Registration Details

10071770882

25351055154201657

50248780000161

Company Information

Dates and Status

Mar 27, 2017

27/03/2027

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2)"